Literature DB >> 21977194

Update in hematology.

Anca Ciobanu1, Oana Ciocan, Anca Roxana Lupu.   

Abstract

Year:  2011        PMID: 21977194      PMCID: PMC3150027     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


× No keyword cloud information.
  6 in total

1.  Balancing act for elderly myeloma.

Authors:  Antonio Palumbo
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

2.  Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone.

Authors:  Jean-Luc Harousseau; Antonio Palumbo; Paul G Richardson; Rudolf Schlag; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Alain Kentos; Michele Cavo; Anatoly Golenkov; Mieczyslaw Komarnicki; Maria-Victoria Mateos; Dixie-Lee Esseltine; Andrew Cakana; Kevin Liu; William Deraedt; Helgi van de Velde; Jesús F San Miguel
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

3.  Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma.

Authors:  Anders Waage; Peter Gimsing; Peter Fayers; Niels Abildgaard; Lucia Ahlberg; Bo Björkstrand; Kristina Carlson; Inger Marie Dahl; Karin Forsberg; Nina Gulbrandsen; Einar Haukås; Oyvind Hjertner; Martin Hjorth; Torbjörn Karlsson; Lene Meldgaard Knudsen; Johan Lanng Nielsen; Olle Linder; Ulf-Henrik Mellqvist; Ingerid Nesthus; Jürgen Rolke; Maria Strandberg; Jon Hjalmar Sørbø; Finn Wisløff; Gunnar Juliusson; Ingemar Turesson
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

4.  Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Authors:  Paul G Richardson; Edie Weller; Sagar Lonial; Andrzej J Jakubowiak; Sundar Jagannath; Noopur S Raje; David E Avigan; Wanling Xie; Irene M Ghobrial; Robert L Schlossman; Amitabha Mazumder; Nikhil C Munshi; David H Vesole; Robin Joyce; Jonathan L Kaufman; Deborah Doss; Diane L Warren; Laura E Lunde; Sarah Kaster; Carol Delaney; Teru Hideshima; Constantine S Mitsiades; Robert Knight; Dixie-Lee Esseltine; Kenneth C Anderson
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

5.  High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study.

Authors:  Eduard J Libourel; Pieter Sonneveld; Bronno van der Holt; Moniek P M de Maat; Frank W G Leebeek
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

6.  Improved survival in multiple myeloma and the impact of novel therapies.

Authors:  Shaji K Kumar; S Vincent Rajkumar; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; Steven R Zeldenrust; David Dingli; Stephen J Russell; John A Lust; Philip R Greipp; Robert A Kyle; Morie A Gertz
Journal:  Blood       Date:  2007-11-01       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.